AAAAAA
Results:
1-20
|
Results: 20
Authors:
Friedrich, K
Wieder, T
Von Haefen, C
Radetzki, S
Janicke, R
Schulze-Osthoff, K
Dorken, B
Daniel, PT
Citation: K. Friedrich et al., Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance, ONCOGENE, 20(22), 2001, pp. 2749-2760
Authors:
Daniel, PT
Wieder, T
Sturm, I
Schulze-Osthoff, K
Citation: Pt. Daniel et al., The kiss of death: promises and failures of death receptors and ligands incancer therapy, LEUKEMIA, 15(7), 2001, pp. 1022-1032
Authors:
Wieder, T
Prokop, A
Bagci, B
Essmann, F
Bernicke, D
Schulze-Osthoff, K
Dorken, B
Schmalz, HG
Daniel, PT
Henze, G
Citation: T. Wieder et al., Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts, LEUKEMIA, 15(11), 2001, pp. 1735-1742
Authors:
Petrowsky, H
Sturm, I
Graubitz, O
Kooby, DA
Staib-Sebler, E
Gog, C
Kohne, CH
Hillebrand, T
Daniel, PT
Fong, Y
Lorenz, M
Citation: H. Petrowsky et al., Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases, EUR J SUR O, 27(1), 2001, pp. 80-87
Authors:
Sturm, I
Petrowsky, H
Volz, R
Lorenz, M
Radetzki, S
Hillebrand, T
Wolff, G
Hauptmann, S
Dorken, B
Daniel, PT
Citation: I. Sturm et al., Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: High BAX and p16(nk4a/CDKN2) identifies patients with good prognosis, J CL ONCOL, 19(8), 2001, pp. 2272-2281
Authors:
Raisova, M
Hossini, AM
Eberle, J
Riebeling, C
Wieder, T
Sturm, I
Daniel, PT
Orfanos, CE
Geilen, CC
Citation: M. Raisova et al., The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis, J INVES DER, 117(2), 2001, pp. 333-340
Authors:
Hermann, S
Sturm, I
Mrozek, A
Klosterhalfen, B
Hauptmann, S
Dorken, B
Daniel, PT
Citation: S. Hermann et al., Bax expression in benign and malignant thyroid tumours: Dysregulation of wild-type p53 is associated with a high bax and p21 expression in thyroid carcinoma, INT J CANC, 92(6), 2001, pp. 805-811
Authors:
Wieder, T
Essmann, F
Prokop, A
Schmelz, K
Schulze-Osthoff, K
Beyaert, R
Dorken, B
Daniel, PT
Citation: T. Wieder et al., Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream ofcaspase-3, BLOOD, 97(5), 2001, pp. 1378-1387
Authors:
Prokop, A
Wieder, T
Sturm, I
Essmann, E
Seeger, K
Wuchter, C
Ludwig, WD
Henze, G
Dorken, B
Daniel, PT
Citation: A. Prokop et al., Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo, LEUKEMIA, 14(9), 2000, pp. 1606-1613
Authors:
Daniel, PT
Citation: Pt. Daniel, Dissecting the pathways to death, LEUKEMIA, 14(12), 2000, pp. 2035-2044
Authors:
Essmann, F
Wieder, T
Otto, A
Muller, EC
Dorken, B
Daniel, PT
Citation: F. Essmann et al., GDP dissociation inhibitor D4-GDI (Rho-GDI 2), but not the homologous Rho-GDI 1, is cleaved by caspase-3 during drug-induced apoptosis, BIOCHEM J, 346, 2000, pp. 777-783
Authors:
Sturm, I
Papadopoulos, S
Hillebrand, T
Benter, T
Luck, HJ
Wolff, G
Dorken, B
Daniel, PT
Citation: I. Sturm et al., Impaired BAX protein expression in breast cancer: Mutational analysis of the BAX and the p53 gene, INT J CANC, 87(4), 2000, pp. 517-521
Authors:
Loffler, A
Kufer, P
Lutterbuse, R
Zettl, F
Daniel, PT
Schwenkenbecher, JM
Riethmuller, G
Dorken, B
Bargou, RC
Citation: A. Loffler et al., A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes, BLOOD, 95(6), 2000, pp. 2098-2103
Authors:
Daniel, PT
Sturm, I
Wolff, G
Petrowsky, H
Kohne, CH
Hillebrand, T
Dorker, B
Lorenz, M
Citation: Pt. Daniel et al., Analysis of the p53/BAX pathway: Low BAX expression is a negative prognostic factor in patients with resected liver metastases of colorectal adenocarcinoma, LANG ARCH S, 1999, pp. 163-169
Authors:
Sturm, I
Kohne, CH
Wolff, G
Petrowsky, H
Hillebrand, T
Hauptmann, S
Lorenz, M
Dorken, B
Daniel, PT
Citation: I. Sturm et al., Analysis of the p53/BAX pathway in colorectal cancer: Low BAX is a negative prognostic factor in patients with resected liver metastases, J CL ONCOL, 17(5), 1999, pp. 1364-1374
Authors:
Daniel, PT
Scholz, C
Essmann, F
Westermann, J
Pezzutto, A
Dorken, B
Citation: Pt. Daniel et al., CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanism, EXP HEMATOL, 27(9), 1999, pp. 1402-1408
Authors:
Daniel, PT
Pun, KT
Ritschel, S
Sturm, I
Holler, J
Dorken, B
Brown, R
Citation: Pt. Daniel et al., Expression of the death gene Bik/Nbk promotes sensitivity to drug-induced apoptosis in corticosteroid-resistant T-cell lymphoma and prevents tumor growth in severe combined immunodeficient mice, BLOOD, 94(3), 1999, pp. 1100-1107
Authors:
Daniel, PT
Sturm, I
Ritschel, S
Friedrich, K
Dorken, B
Bendzko, P
Hillebrand, T
Citation: Pt. Daniel et al., Detection of genomic DNA fragmentation during apoptosis (DNA ladder) and the simultaneous isolation of RNA from low cell numbers, ANALYT BIOC, 266(1), 1999, pp. 110-115
Authors:
Daniel, PT
Pezzutto, A
Dorken, B
Citation: Pt. Daniel et al., Humoral immunotherapy and the use of monoclonal antibodies, TEXTBOOK OF MALIGNANT HAEMATOLOGY, 1999, pp. 425-446
Authors:
Daniel, PT
Kroidl, A
Kopp, J
Sturm, I
Moldenhauer, G
Dorken, B
Pezzutto, A
Citation: Pt. Daniel et al., Immunotherapy of B-cell lymphoma with CD3x19 bispecific antibodies: Costimulation via CD28 prevents "veto" apoptosis of antibody-targeted cytotoxic Tcells, BLOOD, 92(12), 1998, pp. 4750-4757
Risultati:
1-20
|